BioNTech SE (BNTX) Raw Materials (2018 - 2021)
BioNTech SE (BNTX) posted Raw Materials of $284.0 million for Q4 2021, up 437.78% sequentially from $52.8 million in Q4 2020, and up 437.78% YoY from $52.8 million in Q4 2020.
BioNTech SE (BNTX) Raw Materials (2018 - 2021) Analysis & Trends
BioNTech SE has reported Raw Materials for 4 years, with the latest figure at $284.0 million in Q4 2021.
- Quarterly Raw Materials rose 437.78% year-over-year to $284.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $284.0 million (up 437.78% YoY) and the FY2021 annual result came in at $293.8 million, up 480.93% from the prior year.
- Raw Materials advanced to $284.0 million in Q4 2021 per BNTX's latest filing, from $52.8 million in the prior quarter.
- Over five years, Raw Materials peaked at $284.0 million in Q4 2021 and troughed at $5.1 million in Q4 2018.
- A 4-year average of $87.8 million and a median of $30.9 million in 2020 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2019 and 2020: Raw Materials jumped 77.72% in 2019, then jumped 481.86% in 2020.
- Over 4 years, Raw Materials stood at $5.1 million in 2018, then surged by 77.72% to $9.1 million in 2019, then surged by 481.86% to $52.8 million in 2020, then soared by 437.78% to $284.0 million in 2021.
- According to Business Quant data, Raw Materials over the past three periods registered $284.0 million, $52.8 million, and $9.1 million for Q4 2021, Q4 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 284.05 Mn |
| Dec 31, 2020 | 52.82 Mn |
| Dec 31, 2019 | 9.08 Mn |
| Dec 31, 2018 | 5.11 Mn |